This Animal Origin Policy Statement applies to all products which are manufactured by Miltenyi Biotec and for which the intended use provides for contact with human cells and tissues as excipient or ex vivo. For RUO products and product for analysis only (IVD/ASRs) this statement does not apply.
Miltenyi Biotec recognizes that product traceability is an important requirement for our customers, and therefore information on issues related to the origin and risk of products containing or manufactured with materials from animal/human source are provided. To fulfill the requirements, Miltenyi Biotec has established a certified ISO 13485 quality management system to achieve highest safety of our products with the lowest risk to our customers.
Production processes at Miltenyi Biotec are developed to avoid the use of animal, human or viral components. Information and review regarding the origin of all materials used for the manufacturing of Miltenyi Biotec products is part of the release process of the raw material before using the components in manufacturing.
If the use of animal/human derived materials purchased or manufactured by Miltenyi Biotec is absolutely necessary for the manufacture of functioning products, the quality of these materials complies with recognized quality standards, e.g. compendial grade, or with other standards, guidance (EMA/410/01) and legislation related to the safety of these materials.
Suppliers of Miltenyi Biotec are actively engaged to provide information on the origin, traceability and processing, to assess the safety of our purchased materials used in manufacturing and for materials purchased for resale. Each material of animal/human origin purchased by Miltenyi Biotec requires at least a Certificate of Origin (CoO) stating e.g. source, country of origin, country of material manufacture or a EMA/410/01 certificate from the supplier. The zoonotic/anthroponotic risk of purchased animal/human materials is evaluated in a risk based manner. Miltenyi Biotec differentiates between materials which are a part of the final product and materials with contact to the final product during the manufacturing process. For materials of animal/human origin or their derivatives manufactured by Miltenyi Biotec itself, internal data on origin and processing are used for respective traceability and risk assessment. For materials presenting a TSE risk, both origin and inactivation/removal data are combined for the risk assessment of a possible transmission of an infectious TSE agent. Based on the risk evaluation of a material of animal/human origin or its derivative, Miltenyi Biotec issues either a CoO or a TSE/BSE statement for its products.
A Miltenyi Biotec Certificate of Origin provides all necessary information about the product so customer can perform a TSE/BSE risk assessment based upon its intended use in their specific application.
MACS GMP Media and Peptides
The raw materials of MACS GMP labeled cell culture media are chemically defined, like e.g. salts, amino acids, fatty acids, vitamins, buffers which are manufactured or isolated from defined sources and are not animal- or human derived, unless otherwise stated. If human serum albumin (HSA) or human platelet lysate is part of the MACS GMP cell culture medium, this is specified in the Certificate of Origin of the product. Only well characterized licensed biologics from certified facilities that control the donor pool and appropriately screen the individual donors for relevant human infectious diseases are used. If recombinant human serum albumin is part of the MACS GMP cell culture medium, this do not contain animal-derived materials. No animal-derived components are used for manufacture of MACS GMP cell culture media. Raw materials for MACS GMP PepTivator products are synthetically prepared and do not contain animal-, human-, or virus-derived materials.
MACS GMP Cytokines
Raw materials of MACS GMP Cytokine products are manufactured from defined sources and are not animal-, or human-derived, unless otherwise stated. If recombinant human serum albumin is used, this do not contain animal-derived materials. For the cultivation of microorganism in the up-stream process bovine milk derivatives of pharmaceutical grade may be used. Furthermore, recombinant enzymes especially developed for the biopharmaceutical production produced by fermentation with bovine milk derivatives may be used. According EMA/410/01 current version milk derivatives are unlikely to present any risk of TSE contamination. The compliance with the Note for Guidance EMA/410/01 current version for the manufacture of the used milk derivatives must be demonstrated by the supplier in the TSE/BSE certificate. Therefore, the risk of TSE/BSE possibly arising from this raw material is reduced to an utmost minimum. Miltenyi Biotec specifies the use of these raw materials on the Certificate of Origin for the products in which these raw materials are used. The suppliers of raw materials and materials that are used in the course of production of MACS GMP products and get temporarily contact with the product are requested to provide information on the origin.
MACS GMP monoclonal antibodies and antibody-based reagents
Monoclonal antibodies are derivatives from animal tissue but do not contain high infectivity tissues according to the Note for Guidance EMA/410/01 current version. Miltenyi Biotec will declare for the MACS GMP products, that no animal- or human-derived components were used for the manufacture of this product, unless otherwise stated in the respective Certificate of Origin. This information provided in this statement is given to the best of our knowledge and belief, and is based on the information available at the time of this statement was issued.